Last reviewed: July 16, 2026
Last updated: July 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many people wonder whether Mounjaro is an insulin injection, but the answer is no. Mounjaro contains tirzepatide, a dual receptor agonist approved for type 2 diabetes that works through two separate hormonal mechanisms to lower blood sugar and body weight. PlexusDx offers compounded tirzepatide injections starting at $289/mo (or $249/mo on the 6-month plan) as a personalized alternative.
What Is Tirzepatide and How Does It Differ From Insulin?
Tirzepatide is a synthetic peptide that mimics two natural hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Unlike insulin, which is a hormone your pancreas produces to move glucose directly into cells, tirzepatide works indirectly by stimulating your body's own insulin release when blood sugar rises. This dual-action approach makes tirzepatide fundamentally different from traditional insulin therapy, which requires direct insulin replacement.
Insulin therapy becomes necessary when the pancreas cannot produce enough insulin on its own, a common scenario in advanced type 2 diabetes or type 1 diabetes. Tirzepatide, by contrast, enhances your existing insulin signaling and helps your pancreas function more efficiently. Clinical trials showed that tirzepatide reduced HbA1c (a 3-month blood sugar average) by 2.5% to 2.7% in patients with type 2 diabetes, offering substantial glucose control without direct insulin injection.
How Tirzepatide Controls Blood Sugar and Body Weight
Tirzepatide's dual mechanism targets two distinct pathways in the body. The GLP-1 pathway slows stomach emptying, increases feelings of fullness, and stimulates insulin secretion. The GIP pathway enhances the GLP-1 effect and contributes to additional metabolic improvements. Together, these actions lower blood sugar levels and reduce appetite, which is why many patients experience significant weight loss alongside glucose control. In clinical trials, patients lost between 15 to 22 pounds on tirzepatide over 88 weeks.
The medication also improves how your body's cells respond to insulin—a process called insulin sensitivity. By making insulin work more effectively, tirzepatide reduces the amount of circulating glucose and may slow the progression of diabetes. This improvement in insulin sensitivity differentiates tirzepatide from insulin replacement therapy, which bypasses the need for your body's natural insulin signaling entirely.
Tirzepatide Injections vs. Oral Formulations: What's the Difference?
Tirzepatide is available in two forms: injectable and oral. The injectable version, delivered under the skin once weekly, has stronger clinical evidence for blood sugar and weight reduction. PlexusDx compounds tirzepatide injections from licensed 503A compounding pharmacies, starting at $289 per month, offering the same active ingredient as brand-name Mounjaro but at a more accessible price point. Oral tirzepatide begins at $349/mo (or $279/mo on the 6-month plan) through PlexusDx and may be preferred by patients who dislike needles, though its absorption and efficacy can be less predictable.
Both forms require dose adjustments over several weeks to find the optimal level for each patient. PlexusDx uses the pricing model 'Your dose may need to go up. Your price won't,' meaning patients pay a flat monthly rate regardless of whether their dose increases during treatment. This approach removes cost barriers to reaching therapeutic doses and ensures patients can access the full benefit of tirzepatide therapy.
Is Tirzepatide Right for Your Diabetes Plan? Genetic Insights Matter
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
PlexusDx maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights to match you with the most effective medication. The genetic test is available as a $99 add-on after your first month of treatment, providing data-driven guidance for long-term diabetes management. By combining genetic testing with compounded tirzepatide therapy, PlexusDx enables precision medicine tailored to your unique biology.
Cost and Access: Compounded Tirzepatide Without Insurance
One major barrier to tirzepatide therapy has been cost, especially for uninsured patients. PlexusDx makes compounded tirzepatide injectable accessible at $289 per month flat, with no insurance required and no membership fees. The medication is prepared by licensed 503A compounding pharmacies, ensuring safety and consistency while reducing the commercial markup associated with brand-name alternatives. Oral tirzepatide through PlexusDx starts at $349/mo (or $279/mo on the 6-month plan).
Patients can use HSA or FSA accounts to pay for PlexusDx medications, providing additional tax-advantaged savings. PlexusDx serves all 50 states and ships directly to your home, eliminating frequent pharmacy visits. For those already using other GLP-1 therapies and seeking to upgrade to dual-action tirzepatide, the clear pricing and no-insurance-needed model makes switching straightforward and affordable.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Mounjaro the same as insulin?
No. Mounjaro contains tirzepatide, which is not insulin but a dual GLP-1/GIP receptor agonist. It works by enhancing your body's own insulin response rather than replacing insulin directly. Tirzepatide helps your pancreas secrete insulin more effectively when blood sugar rises, whereas insulin injections deliver synthetic hormone directly into your bloodstream.
Can tirzepatide replace insulin therapy in type 2 diabetes?
Tirzepatide can significantly improve blood sugar control and may reduce the need for insulin in many type 2 diabetes patients. However, some advanced cases may still require insulin or tirzepatide as add-on therapy. A healthcare provider should evaluate your specific glucose levels, kidney function, and diabetes duration to determine whether tirzepatide alone is sufficient or whether insulin must be added.
What is the cost difference between brand Mounjaro and PlexusDx compounded tirzepatide?
Brand-name Mounjaro typically costs $900–$1,350 per month without insurance. PlexusDx compounded tirzepatide injections start at $289/mo (or $249/mo on the 6-month plan) flat, with no flat per-compound pricing increases. This 70–80% savings applies to all 50 states with no insurance required, and patients can use HSA or FSA accounts for additional tax savings.
What are the most common side effects of tirzepatide?
Common side effects include nausea, vomiting, diarrhea, and constipation, especially during dose increases. Most side effects are mild and improve within 1–2 weeks as your body adjusts. Serious adverse events are rare but may include pancreatitis or gallbladder issues; notify your provider immediately if you experience severe abdominal pain.
How does the PlexusDx Precision Peptide Genetic Test improve tirzepatide therapy?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Compounded Mounjaro Safe? What You Need to Know About This Weight Loss Option
Will My Insurance Cover Mounjaro for Weight Loss?